Avallano Releases ProtocolCopilot™: Powering Clinical Research with AI-driven Protocol Assistance
16 Julio 2024 - 5:00AM
Business Wire
Avallano is launching ProtocolCopilot™, an innovative
AI-driven clinical research protocol assistant designed to
transform the way biopharmaceutical companies and clinical research
sites manage and interact with complex clinical trial
protocols.
ProtocolCopilot leverages advanced artificial
intelligence to streamline the process of understanding and
adhering to clinical research protocols. By providing a chatbot
interface, it ensures that users can effortlessly access crucial
protocol information without the need to navigate through
cumbersome documents. Key features of ProtocolCopilot™ include:
- AI-powered Information Retrieval: Utilizes sophisticated
AI to ingest, process, and respond to specific questions about a
protocol, eliminating the need for manual searches and hyperlink
navigation.
- Enhanced Usability: Delivers answers directly to users'
questions, enabling them to bypass the time-consuming process of
scanning lengthy documents.
- Memory Refresher: Facilitates quick reference checks,
aiding users in recalling specific protocol procedures
effortlessly.
- User-friendly Learning: Provides an engaging and
intuitive platform for users to familiarize themselves with
protocol details, enhancing overall user experience.
- Compliance Support: Promotes adherence to proper
procedures, inclusions/exclusions, and drug-related queries,
particularly under tight schedules and heavy workloads.
- Mobile Accessibility: Offers a convenient, on-the-go
reference solution for busy site staff juggling multiple
studies.
- Customizable Outputs: Can be tailored to provide answers
in various languages and at suitable reading levels, accommodating
diverse user needs.
- “Correct AI” Assurance: Implements a rigorous process to
ensure that responses are factual, protocol-based, and
accurate.
With ProtocolCopilot, clinical research professionals can
focus more on critical tasks rather than getting bogged down by
extensive protocol documents. This tool is especially beneficial
for site staff who are often overwhelmed by the cognitive demands
of managing numerous studies simultaneously.
“We are excited to bring ProtocolCopilot™ to the market,
offering a cutting-edge solution that not only enhances efficiency
but also supports compliance and accuracy in clinical research,”
said Paul Della Maggiora, CEO of Avallano. “By leveraging the power
of AI, we are addressing a significant pain point in the industry
and empowering research professionals with a tool that understands
their needs.”
Avallano is seeking early partners for the testing and
deployment of ProtocolCopilot™. To learn more or request a
demonstration, please contact Jillian Stamatis.
About Avallano
Avallano is an AI-enabled clinical trial solutions organization
with a single platform to find, engage, and retain patients before,
during, and after trials. We are dedicated to providing solutions
that use “correct AI” to focus on the patient, decrease cognitive
burden, and simplify clinical trials. Our mission is to bring
clinical research back to patients using regulatory-compliant
technology.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240716079009/en/
Jillian Stamatis Business Development Avallano
Jillian@avallano.com (847) 391-9893